These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2360913)

  • 41. ACAT inhibitors CL 283,546 and CL 283,796 reduce LDL cholesterol without affecting cholesterol absorption in African green monkeys.
    Wrenn SM; Parks JS; Immermann FW; Rudel LL
    J Lipid Res; 1995 Jun; 36(6):1199-210. PubMed ID: 7665998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
    Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the ACAT inhibitor CL 277,082 on apolipoprotein B48 transport in mesenteric lymph and on plasma clearance of chylomicrons and remnants.
    Martins IJ; Mortimer BC; Redgrave TG
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):211-6. PubMed ID: 9012658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of rat hepatic cholesterol metabolism. Effects of lipoprotein composition on acyl coenzyme A:cholesterol acyltransferase in vivo and in the perfused liver and on hepatic cholesterol secretion.
    Van Zuiden PE; Cooper AD; Erickson SK
    J Lipid Res; 1987 Aug; 28(8):930-40. PubMed ID: 3668389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
    Graham A; Wood JL; Russell LJ
    Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acyl-CoA: cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in carp-liver microsomes: effect of cold acclimation on enzyme activities and on hepatic and plasma lipid composition.
    Teichert T; Wodtke E
    Biochim Biophys Acta; 1992 Dec; 1165(2):211-21. PubMed ID: 1450216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
    Vaziri ND; Sato T; Liang K
    Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
    Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
    J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The enzymes related to lipoprotein metabolism (LpL, H-TGL, LCAT, ACAT, HMG-CoA reductase, 7 alpha-hydroxylase)].
    Inadera H; Shirai K; Saito Y
    Nihon Rinsho; 1990 Nov; 48(11):2483-91. PubMed ID: 2270012
    [No Abstract]   [Full Text] [Related]  

  • 53. Homeostatic restoration of microsomal lipids and enzyme changes in HMG-CoA reductase and acyl-CoA: cholesterol acyltransferase in chick liver.
    Garcia-Gonzalez M; Segovia JL; Alejandre MJ
    Mol Cell Biochem; 1992 Oct; 115(2):173-8. PubMed ID: 1448062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
    Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
    Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ontogeny of acyl-CoA: cholesterol acyltransferase in rat liver, intestine, and adipose tissue.
    Little MT; Hahn P
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G599-602. PubMed ID: 1566841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats.
    Lee MK; Moon SS; Lee SE; Bok SH; Jeong TS; Park YB; Choi MS
    Bioorg Med Chem; 2003 Feb; 11(3):393-8. PubMed ID: 12517434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
    Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
    Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lovastatin on acyl-CoA: cholesterol O-acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells.
    Kam NT; Albright E; Mathur S; Field FJ
    Biochem J; 1990 Dec; 272(2):427-33. PubMed ID: 2268271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Citrus pectin and cholesterol interact to regulate hepatic cholesterol homeostasis and lipoprotein metabolism: a dose-response study in guinea pigs.
    Fernandez ML; Sun DM; Tosca MA; McNamara DJ
    Am J Clin Nutr; 1994 Apr; 59(4):869-78. PubMed ID: 8147332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.